Study of efficacy and antibody duration to fourth-dose booster of Ad5-nCoV or inactivated SARS-CoV-2 vaccine in Chinese adults: a prospective cohort study

INTRODUCTION: China experienced a record surge of coronavirus disease 2019 cases in December 2022, during the pandemic. METHODS: We conducted a randomized, parallel-controlled prospective cohort study to evaluate efficacy and antibody duration after a fourth-dose booster with Ad5-nCoV or inactivated...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Nani, Xu, Yu, Dai, Rongrong, Zheng, Lin, Qin, Pan, Wan, Peng, Yang, Yejing, Jiang, Jianmin, Zhang, Hangjie, Hu, Xiaowei, Lv, Huakun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510200/
https://www.ncbi.nlm.nih.gov/pubmed/37736100
http://dx.doi.org/10.3389/fimmu.2023.1244373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510200/
https://www.ncbi.nlm.nih.gov/pubmed/37736100
http://dx.doi.org/10.3389/fimmu.2023.1244373

Ejemplares similares